MONTREAL, Oct. 29, 2024 /CNW/ - AbbVie (NYSE: ABBV) announced today that Ontario has listed VRAYLAR® (cariprazine) on its provincial formulary as a General Benefit. The listing will be effective on October 31, 2024.
Read more at newswire.cahello world
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
